for the Period Ended 30 September 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 September 2023
Principal activities of the company
Directors
The director shown below has held office during the period of
8 September 2023 to 30 September 2023
The directors shown below have held office during the whole of the period from
8 September 2022 to 30 September 2023
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
13 months to 30 September 2023 | ||
---|---|---|
| £ | |
Turnover: | | |
Cost of sales: | ( | |
Gross profit(or loss): | | |
Distribution costs: | ( | |
Administrative expenses: | | |
Other operating income: | | |
Operating profit(or loss): | | |
Interest receivable and similar income: | | |
Interest payable and similar charges: | | |
Profit(or loss) before tax: | | |
Tax: | ( | |
Profit(or loss) for the financial year: | |
As at
Notes | 13 months to 30 September 2023 | ||
---|---|---|---|
| £ | ||
Fixed assets | |||
Intangible assets: | | ||
Tangible assets: | | ||
Investments: | | ||
Total fixed assets: | | ||
Current assets | |||
Stocks: | | ||
Debtors: | | ||
Cash at bank and in hand: | | ||
Investments: | | ||
Total current assets: | | ||
Prepayments and accrued income: | | ||
Creditors: amounts falling due within one year: | | ||
Net current assets (liabilities): | | ||
Total assets less current liabilities: | | ||
Creditors: amounts falling due after more than one year: | | ||
Provision for liabilities: | | ||
Accruals and deferred income: | ( | ||
Total net assets (liabilities): | | ||
Members' funds | |||
Profit and loss account: | | ||
Total members' funds: | |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 September 2023
Basis of measurement and preparation
Turnover policy
for the Period Ended 30 September 2023
13 months to 30 September 2023 | ||
---|---|---|
Average number of employees during the period | |
The Head and Neck Cancer Coalition is a group of 15 members comprising charities, support groups and healthcare associations who have come together to create one strong voice for all those affected by Head and Neck cancers in the UK. We are pooling our collective resources to raise awareness and create better understanding of all aspects of Head and Neck cancer.The members work together on focused objectives and projects within the areas of patient and caregiver support, awareness and education, research, policy, multidisciplinary team support and patient pathway improvements. The Coalition will take a collaborative, inclusive and multi-perspective approach to ensure the complexity of Head and Neck Cancers are addressed. A joined-up approach will allow us to have greater alignment on messaging, ensure all voices are heard and collaborate on key priorities to ensure we have greater collective impact. Together we will improve the patient and caregiver experience and outcomes.We will support all Head and Neck cancer stakeholders by working together on focused objectives and projects within the areas of patient and caregiver support, awareness and education, research, policy, multidisciplinary team support and patient pathway improvements.
As noted above, the coalition exists as a way of bringing together representatives from 15-different organisations which represent head and neck cancer patients, their clinicians and the general public in the UK. Our main stakeholders are therefore the 15-organisations, and they meet together on a quarterly basis to share their work and to communicate their priorities to others. Those who attend the meetings are trustees and the senior staff of organisations and the coalition asks that each of member organisations provides visibility of our work to their boards and members. Activities during the year have included carrying out a detailed and in-depth consultation with our members on what our priorities should be, the order in which they should be approached and actions that the coalition can take in order to raise awareness of head and neck cancers.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
5 June 2024
And signed on behalf of the board by:
Name: Alastair Richards
Status: Director